Global Biotechnology Services Market
Global Biotechnology Services Market

Biotechnology Services Comprehensive Study by Application (Pharmaceutical, Clinical Trial, Healthcare Sectors), Technology (Tissue Engineering and Regeneration, PCR Technology, Nano Biotechnology, Chromatography, DNA Sequencing, Cell Based Assay, Others), Service Type (Food Biotechnology Services, Donor Recruitment, Tissue Collection, Cell Processing and Isolation, Others) Players and Region - Global Market Outlook to 2027

Biotechnology Services Market Segmented into XX Submarkets. | Forecast Years: 2022- 2027  

Apr 2022 Edition 225 Pages 219 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Global Biotechnology Services Market Overview:
Biotechnology is an interdisciplinary, forward-thinking field that uses living creatures, biological systems, or derivatives to modify or develop processes and outcomes for the development of healthcare goods and medicines. It has a significant impact on a variety of industries, including medicine and pharmaceuticals, genetics, and food and chemical production. It offers a wide range of applications in solving crucial issues such as health and well-being, food and energy security, and environmental protection. The biotechnology services market is made up of companies that sell biotechnology services and related items to companies that do biotechnology research and development. Included are only commodities and services that are transferred between businesses or sold to end users.

Growth Drivers
  • Rising Demand for Agriculture Based Products
  • Growing Incidence of Chronic Ailments Worldwide

Roadblocks
  • High Research and Development Costs

Opportunities
  • Favorable Government Initiatives are Leading the Growth of Biotech Sector in Developing Economies
  • Growing Advancements in Life Sciences are Offering Numerous Benefits Associated with Healthcare Interventions and Productivity by Incorporating Innovative Technology

Challenges
  • High Risk associated to Genetic Data


Competitive Landscape:
The demand for Biotechnology Services is increasing with each passing day. The businesses in this industry facing major competition with leading players of the market that includes Pfizer, Fisher BioServices Inc, Aldevron LLC and others. Many international as well as regional providers are also participants in the industry and directly compete with leaders. It has been identified that market leading players are investing heavily in growth strategies such as technological development, resource utilization to enhance their market position. The market leaders such as Pfizer, Fisher BioServices Inc, Aldevron LLC. Company demonstrate a market-defining vision of how biotechnology services can help top-line business executives achieve their business objectives. Leaders have the ability to execute against that vision through both products and services. They have demonstrated solid business results in the form of revenue and earnings.
Some of the key players profiled in the report are Fisher BioServices Inc. (United States), Pfizer (United States), Sartorius (Germany), Aldevron LLC (United States), AstraZeneca (United Kingdom), Gilead Sciences, Inc. (United States), Biogen (United States), Amgen Inc. (United States), Merck & Co. (United States), Sanofi (France), Roche Holding AG (Switzerland) and Lonza Group AG (Switzerland). Additionally, following companies can also be profiled that are part of our coverage like Regeneron Pharmaceuticals (United States), Alexion Pharmaceuticals (United States), Vertex Pharmaceuticals (United States) and Incyte Corp. (United States). Analyst at AMA Research see United States Players to retain maximum share of Global Biotechnology Services market by 2027. Considering Market by Technology, the sub-segment i.e. Tissue Engineering and Regeneration will boost the Biotechnology Services market. Considering Market by Service Type, the sub-segment i.e. Food Biotechnology Services will boost the Biotechnology Services market.

Latest Market Insights:
In March 2021 Amgen had announced the acquisition of Rodeo. Rodeo is a biopharmaceutical company focused on the development of small-molecule therapies to aid in the regeneration and repair of certain tissues. This acquisition will enable Amgen to offer innovative biopharmaceutical products and reclaim its market position.

What Can be Explored with the Biotechnology Services Market Study
 Gain Market Understanding
 Identify Growth Opportunities
 Analyze and Measure the Global Biotechnology Services Market by Identifying Investment across various Industry Verticals
 Understand the Trends that will drive Future Changes in Biotechnology Services
 Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals

Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Biotechnology Services market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Biotechnology Services market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Venture and Capitalist, New entrants/investors, Analysts and Strategic Business Partners, Pharmaceuticals, Healthcare Companies and End-use industries.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.

Frequently Asked Questions (FAQ):

1. What is the growth rate predicted for the Global Biotechnology Services Market?
The Biotechnology Services market is expected to see a CAGR of % during projected year 2021 to 2027.

2. Who are the top performing companies in Biotechnology Services Market?
Top performing companies in the Global Biotechnology Services market are Fisher BioServices Inc. (United States), Pfizer (United States), Sartorius (Germany), Aldevron LLC (United States), AstraZeneca (United Kingdom), Gilead Sciences, Inc. (United States), Biogen (United States), Amgen Inc. (United States), Merck & Co. (United States), Sanofi (France), Roche Holding AG (Switzerland) and Lonza Group AG (Switzerland), to name a few.

3. What trending factors would impact Biotechnology Services Market growth most?
"Rapid Development of Cloud Computing Technology in Biotechnology " is seen as one of major influencing trends for Biotechnology Services Market during projected period 2021-2027.

Report Objectives / Segmentation Covered
By Application
  • Pharmaceutical
  • Clinical Trial
  • Healthcare Sectors
By Technology
  • Tissue Engineering and Regeneration
  • PCR Technology
  • Nano Biotechnology
  • Chromatography
  • DNA Sequencing
  • Cell Based Assay
  • Others

By Service Type
  • Food Biotechnology Services
  • Donor Recruitment
  • Tissue Collection
  • Cell Processing and Isolation
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Demand for Agriculture Based Products
      • 3.2.2. Growing Incidence of Chronic Ailments Worldwide
    • 3.3. Market Challenges
      • 3.3.1. High Risk associated to Genetic Data
    • 3.4. Market Trends
      • 3.4.1. Rapid Development of Cloud Computing Technology in Biotechnology
      • 3.4.2. Emergence of Monoclonal Antibodies and Biosimilars
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Biotechnology Services, by Application, Technology, Service Type and Region (value and price ) (2016-2021)
    • 5.1. Introduction
    • 5.2. Global Biotechnology Services (Value)
      • 5.2.1. Global Biotechnology Services by: Application (Value)
        • 5.2.1.1. Pharmaceutical
        • 5.2.1.2. Clinical Trial
        • 5.2.1.3. Healthcare Sectors
      • 5.2.2. Global Biotechnology Services by: Technology (Value)
        • 5.2.2.1. Tissue Engineering and Regeneration
        • 5.2.2.2. PCR Technology
        • 5.2.2.3. Nano Biotechnology
        • 5.2.2.4. Chromatography
        • 5.2.2.5. DNA Sequencing
        • 5.2.2.6. Cell Based Assay
        • 5.2.2.7. Others
      • 5.2.3. Global Biotechnology Services by: Service Type (Value)
        • 5.2.3.1. Food Biotechnology Services
        • 5.2.3.2. Donor Recruitment
        • 5.2.3.3. Tissue Collection
        • 5.2.3.4. Cell Processing and Isolation
        • 5.2.3.5. Others
      • 5.2.4. Global Biotechnology Services Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Biotechnology Services (Price)
  • 6. Biotechnology Services: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2021)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Fisher BioServices Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Pfizer (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Sartorius (Germany)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Aldevron LLC (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. AstraZeneca (United Kingdom)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Gilead Sciences, Inc. (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Biogen (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Amgen Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Merck & Co. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sanofi (France)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
      • 6.4.11. Roche Holding AG (Switzerland)
        • 6.4.11.1. Business Overview
        • 6.4.11.2. Products/Services Offerings
        • 6.4.11.3. Financial Analysis
        • 6.4.11.4. SWOT Analysis
      • 6.4.12. Lonza Group AG (Switzerland)
        • 6.4.12.1. Business Overview
        • 6.4.12.2. Products/Services Offerings
        • 6.4.12.3. Financial Analysis
        • 6.4.12.4. SWOT Analysis
  • 7. Global Biotechnology Services Sale, by Application, Technology, Service Type and Region (value and price ) (2022-2027)
    • 7.1. Introduction
    • 7.2. Global Biotechnology Services (Value)
      • 7.2.1. Global Biotechnology Services by: Application (Value)
        • 7.2.1.1. Pharmaceutical
        • 7.2.1.2. Clinical Trial
        • 7.2.1.3. Healthcare Sectors
      • 7.2.2. Global Biotechnology Services by: Technology (Value)
        • 7.2.2.1. Tissue Engineering and Regeneration
        • 7.2.2.2. PCR Technology
        • 7.2.2.3. Nano Biotechnology
        • 7.2.2.4. Chromatography
        • 7.2.2.5. DNA Sequencing
        • 7.2.2.6. Cell Based Assay
        • 7.2.2.7. Others
      • 7.2.3. Global Biotechnology Services by: Service Type (Value)
        • 7.2.3.1. Food Biotechnology Services
        • 7.2.3.2. Donor Recruitment
        • 7.2.3.3. Tissue Collection
        • 7.2.3.4. Cell Processing and Isolation
        • 7.2.3.5. Others
      • 7.2.4. Global Biotechnology Services Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Biotechnology Services (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Biotechnology Services: by Application(USD Million)
  • Table 2. Biotechnology Services Pharmaceutical , by Region USD Million (2016-2021)
  • Table 3. Biotechnology Services Clinical Trial , by Region USD Million (2016-2021)
  • Table 4. Biotechnology Services Healthcare Sectors , by Region USD Million (2016-2021)
  • Table 5. Biotechnology Services: by Technology(USD Million)
  • Table 6. Biotechnology Services Tissue Engineering and Regeneration , by Region USD Million (2016-2021)
  • Table 7. Biotechnology Services PCR Technology , by Region USD Million (2016-2021)
  • Table 8. Biotechnology Services Nano Biotechnology , by Region USD Million (2016-2021)
  • Table 9. Biotechnology Services Chromatography , by Region USD Million (2016-2021)
  • Table 10. Biotechnology Services DNA Sequencing , by Region USD Million (2016-2021)
  • Table 11. Biotechnology Services Cell Based Assay , by Region USD Million (2016-2021)
  • Table 12. Biotechnology Services Others , by Region USD Million (2016-2021)
  • Table 13. Biotechnology Services: by Service Type(USD Million)
  • Table 14. Biotechnology Services Food Biotechnology Services , by Region USD Million (2016-2021)
  • Table 15. Biotechnology Services Donor Recruitment , by Region USD Million (2016-2021)
  • Table 16. Biotechnology Services Tissue Collection , by Region USD Million (2016-2021)
  • Table 17. Biotechnology Services Cell Processing and Isolation , by Region USD Million (2016-2021)
  • Table 18. Biotechnology Services Others , by Region USD Million (2016-2021)
  • Table 19. South America Biotechnology Services, by Country USD Million (2016-2021)
  • Table 20. South America Biotechnology Services, by Application USD Million (2016-2021)
  • Table 21. South America Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 22. South America Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 23. Brazil Biotechnology Services, by Application USD Million (2016-2021)
  • Table 24. Brazil Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 25. Brazil Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 26. Argentina Biotechnology Services, by Application USD Million (2016-2021)
  • Table 27. Argentina Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 28. Argentina Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 29. Rest of South America Biotechnology Services, by Application USD Million (2016-2021)
  • Table 30. Rest of South America Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 31. Rest of South America Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 32. Asia Pacific Biotechnology Services, by Country USD Million (2016-2021)
  • Table 33. Asia Pacific Biotechnology Services, by Application USD Million (2016-2021)
  • Table 34. Asia Pacific Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 35. Asia Pacific Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 36. China Biotechnology Services, by Application USD Million (2016-2021)
  • Table 37. China Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 38. China Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 39. Japan Biotechnology Services, by Application USD Million (2016-2021)
  • Table 40. Japan Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 41. Japan Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 42. India Biotechnology Services, by Application USD Million (2016-2021)
  • Table 43. India Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 44. India Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 45. South Korea Biotechnology Services, by Application USD Million (2016-2021)
  • Table 46. South Korea Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 47. South Korea Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 48. Taiwan Biotechnology Services, by Application USD Million (2016-2021)
  • Table 49. Taiwan Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 50. Taiwan Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 51. Australia Biotechnology Services, by Application USD Million (2016-2021)
  • Table 52. Australia Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 53. Australia Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 54. Rest of Asia-Pacific Biotechnology Services, by Application USD Million (2016-2021)
  • Table 55. Rest of Asia-Pacific Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 56. Rest of Asia-Pacific Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 57. Europe Biotechnology Services, by Country USD Million (2016-2021)
  • Table 58. Europe Biotechnology Services, by Application USD Million (2016-2021)
  • Table 59. Europe Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 60. Europe Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 61. Germany Biotechnology Services, by Application USD Million (2016-2021)
  • Table 62. Germany Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 63. Germany Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 64. France Biotechnology Services, by Application USD Million (2016-2021)
  • Table 65. France Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 66. France Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 67. Italy Biotechnology Services, by Application USD Million (2016-2021)
  • Table 68. Italy Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 69. Italy Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 70. United Kingdom Biotechnology Services, by Application USD Million (2016-2021)
  • Table 71. United Kingdom Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 72. United Kingdom Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 73. Netherlands Biotechnology Services, by Application USD Million (2016-2021)
  • Table 74. Netherlands Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 75. Netherlands Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 76. Rest of Europe Biotechnology Services, by Application USD Million (2016-2021)
  • Table 77. Rest of Europe Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 78. Rest of Europe Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 79. MEA Biotechnology Services, by Country USD Million (2016-2021)
  • Table 80. MEA Biotechnology Services, by Application USD Million (2016-2021)
  • Table 81. MEA Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 82. MEA Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 83. Middle East Biotechnology Services, by Application USD Million (2016-2021)
  • Table 84. Middle East Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 85. Middle East Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 86. Africa Biotechnology Services, by Application USD Million (2016-2021)
  • Table 87. Africa Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 88. Africa Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 89. North America Biotechnology Services, by Country USD Million (2016-2021)
  • Table 90. North America Biotechnology Services, by Application USD Million (2016-2021)
  • Table 91. North America Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 92. North America Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 93. United States Biotechnology Services, by Application USD Million (2016-2021)
  • Table 94. United States Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 95. United States Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 96. Canada Biotechnology Services, by Application USD Million (2016-2021)
  • Table 97. Canada Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 98. Canada Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 99. Mexico Biotechnology Services, by Application USD Million (2016-2021)
  • Table 100. Mexico Biotechnology Services, by Technology USD Million (2016-2021)
  • Table 101. Mexico Biotechnology Services, by Service Type USD Million (2016-2021)
  • Table 102. Company Basic Information, Sales Area and Its Competitors
  • Table 103. Company Basic Information, Sales Area and Its Competitors
  • Table 104. Company Basic Information, Sales Area and Its Competitors
  • Table 105. Company Basic Information, Sales Area and Its Competitors
  • Table 106. Company Basic Information, Sales Area and Its Competitors
  • Table 107. Company Basic Information, Sales Area and Its Competitors
  • Table 108. Company Basic Information, Sales Area and Its Competitors
  • Table 109. Company Basic Information, Sales Area and Its Competitors
  • Table 110. Company Basic Information, Sales Area and Its Competitors
  • Table 111. Company Basic Information, Sales Area and Its Competitors
  • Table 112. Company Basic Information, Sales Area and Its Competitors
  • Table 113. Company Basic Information, Sales Area and Its Competitors
  • Table 114. Biotechnology Services: by Application(USD Million)
  • Table 115. Biotechnology Services Pharmaceutical , by Region USD Million (2022-2027)
  • Table 116. Biotechnology Services Clinical Trial , by Region USD Million (2022-2027)
  • Table 117. Biotechnology Services Healthcare Sectors , by Region USD Million (2022-2027)
  • Table 118. Biotechnology Services: by Technology(USD Million)
  • Table 119. Biotechnology Services Tissue Engineering and Regeneration , by Region USD Million (2022-2027)
  • Table 120. Biotechnology Services PCR Technology , by Region USD Million (2022-2027)
  • Table 121. Biotechnology Services Nano Biotechnology , by Region USD Million (2022-2027)
  • Table 122. Biotechnology Services Chromatography , by Region USD Million (2022-2027)
  • Table 123. Biotechnology Services DNA Sequencing , by Region USD Million (2022-2027)
  • Table 124. Biotechnology Services Cell Based Assay , by Region USD Million (2022-2027)
  • Table 125. Biotechnology Services Others , by Region USD Million (2022-2027)
  • Table 126. Biotechnology Services: by Service Type(USD Million)
  • Table 127. Biotechnology Services Food Biotechnology Services , by Region USD Million (2022-2027)
  • Table 128. Biotechnology Services Donor Recruitment , by Region USD Million (2022-2027)
  • Table 129. Biotechnology Services Tissue Collection , by Region USD Million (2022-2027)
  • Table 130. Biotechnology Services Cell Processing and Isolation , by Region USD Million (2022-2027)
  • Table 131. Biotechnology Services Others , by Region USD Million (2022-2027)
  • Table 132. South America Biotechnology Services, by Country USD Million (2022-2027)
  • Table 133. South America Biotechnology Services, by Application USD Million (2022-2027)
  • Table 134. South America Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 135. South America Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 136. Brazil Biotechnology Services, by Application USD Million (2022-2027)
  • Table 137. Brazil Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 138. Brazil Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 139. Argentina Biotechnology Services, by Application USD Million (2022-2027)
  • Table 140. Argentina Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 141. Argentina Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 142. Rest of South America Biotechnology Services, by Application USD Million (2022-2027)
  • Table 143. Rest of South America Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 144. Rest of South America Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 145. Asia Pacific Biotechnology Services, by Country USD Million (2022-2027)
  • Table 146. Asia Pacific Biotechnology Services, by Application USD Million (2022-2027)
  • Table 147. Asia Pacific Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 148. Asia Pacific Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 149. China Biotechnology Services, by Application USD Million (2022-2027)
  • Table 150. China Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 151. China Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 152. Japan Biotechnology Services, by Application USD Million (2022-2027)
  • Table 153. Japan Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 154. Japan Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 155. India Biotechnology Services, by Application USD Million (2022-2027)
  • Table 156. India Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 157. India Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 158. South Korea Biotechnology Services, by Application USD Million (2022-2027)
  • Table 159. South Korea Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 160. South Korea Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 161. Taiwan Biotechnology Services, by Application USD Million (2022-2027)
  • Table 162. Taiwan Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 163. Taiwan Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 164. Australia Biotechnology Services, by Application USD Million (2022-2027)
  • Table 165. Australia Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 166. Australia Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 167. Rest of Asia-Pacific Biotechnology Services, by Application USD Million (2022-2027)
  • Table 168. Rest of Asia-Pacific Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 169. Rest of Asia-Pacific Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 170. Europe Biotechnology Services, by Country USD Million (2022-2027)
  • Table 171. Europe Biotechnology Services, by Application USD Million (2022-2027)
  • Table 172. Europe Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 173. Europe Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 174. Germany Biotechnology Services, by Application USD Million (2022-2027)
  • Table 175. Germany Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 176. Germany Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 177. France Biotechnology Services, by Application USD Million (2022-2027)
  • Table 178. France Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 179. France Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 180. Italy Biotechnology Services, by Application USD Million (2022-2027)
  • Table 181. Italy Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 182. Italy Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 183. United Kingdom Biotechnology Services, by Application USD Million (2022-2027)
  • Table 184. United Kingdom Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 185. United Kingdom Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 186. Netherlands Biotechnology Services, by Application USD Million (2022-2027)
  • Table 187. Netherlands Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 188. Netherlands Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 189. Rest of Europe Biotechnology Services, by Application USD Million (2022-2027)
  • Table 190. Rest of Europe Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 191. Rest of Europe Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 192. MEA Biotechnology Services, by Country USD Million (2022-2027)
  • Table 193. MEA Biotechnology Services, by Application USD Million (2022-2027)
  • Table 194. MEA Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 195. MEA Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 196. Middle East Biotechnology Services, by Application USD Million (2022-2027)
  • Table 197. Middle East Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 198. Middle East Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 199. Africa Biotechnology Services, by Application USD Million (2022-2027)
  • Table 200. Africa Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 201. Africa Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 202. North America Biotechnology Services, by Country USD Million (2022-2027)
  • Table 203. North America Biotechnology Services, by Application USD Million (2022-2027)
  • Table 204. North America Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 205. North America Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 206. United States Biotechnology Services, by Application USD Million (2022-2027)
  • Table 207. United States Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 208. United States Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 209. Canada Biotechnology Services, by Application USD Million (2022-2027)
  • Table 210. Canada Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 211. Canada Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 212. Mexico Biotechnology Services, by Application USD Million (2022-2027)
  • Table 213. Mexico Biotechnology Services, by Technology USD Million (2022-2027)
  • Table 214. Mexico Biotechnology Services, by Service Type USD Million (2022-2027)
  • Table 215. Research Programs/Design for This Report
  • Table 216. Key Data Information from Secondary Sources
  • Table 217. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Biotechnology Services: by Application USD Million (2016-2021)
  • Figure 5. Global Biotechnology Services: by Technology USD Million (2016-2021)
  • Figure 6. Global Biotechnology Services: by Service Type USD Million (2016-2021)
  • Figure 7. South America Biotechnology Services Share (%), by Country
  • Figure 8. Asia Pacific Biotechnology Services Share (%), by Country
  • Figure 9. Europe Biotechnology Services Share (%), by Country
  • Figure 10. MEA Biotechnology Services Share (%), by Country
  • Figure 11. North America Biotechnology Services Share (%), by Country
  • Figure 12. Global Biotechnology Services share by Players 2021 (%)
  • Figure 13. Global Biotechnology Services share by Players (Top 3) 2021(%)
  • Figure 14. Global Biotechnology Services share by Players (Top 5) 2021(%)
  • Figure 15. BCG Matrix for key Companies
  • Figure 16. Fisher BioServices Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 17. Fisher BioServices Inc. (United States) Revenue: by Geography 2021
  • Figure 18. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 19. Pfizer (United States) Revenue: by Geography 2021
  • Figure 20. Sartorius (Germany) Revenue, Net Income and Gross profit
  • Figure 21. Sartorius (Germany) Revenue: by Geography 2021
  • Figure 22. Aldevron LLC (United States) Revenue, Net Income and Gross profit
  • Figure 23. Aldevron LLC (United States) Revenue: by Geography 2021
  • Figure 24. AstraZeneca (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 25. AstraZeneca (United Kingdom) Revenue: by Geography 2021
  • Figure 26. Gilead Sciences, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 27. Gilead Sciences, Inc. (United States) Revenue: by Geography 2021
  • Figure 28. Biogen (United States) Revenue, Net Income and Gross profit
  • Figure 29. Biogen (United States) Revenue: by Geography 2021
  • Figure 30. Amgen Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 31. Amgen Inc. (United States) Revenue: by Geography 2021
  • Figure 32. Merck & Co. (United States) Revenue, Net Income and Gross profit
  • Figure 33. Merck & Co. (United States) Revenue: by Geography 2021
  • Figure 34. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 35. Sanofi (France) Revenue: by Geography 2021
  • Figure 36. Roche Holding AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 37. Roche Holding AG (Switzerland) Revenue: by Geography 2021
  • Figure 38. Lonza Group AG (Switzerland) Revenue, Net Income and Gross profit
  • Figure 39. Lonza Group AG (Switzerland) Revenue: by Geography 2021
  • Figure 40. Global Biotechnology Services: by Application USD Million (2022-2027)
  • Figure 41. Global Biotechnology Services: by Technology USD Million (2022-2027)
  • Figure 42. Global Biotechnology Services: by Service Type USD Million (2022-2027)
  • Figure 43. South America Biotechnology Services Share (%), by Country
  • Figure 44. Asia Pacific Biotechnology Services Share (%), by Country
  • Figure 45. Europe Biotechnology Services Share (%), by Country
  • Figure 46. MEA Biotechnology Services Share (%), by Country
  • Figure 47. North America Biotechnology Services Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Fisher BioServices Inc. (United States)
  • Pfizer (United States)
  • Sartorius (Germany)
  • Aldevron LLC (United States)
  • AstraZeneca (United Kingdom)
  • Gilead Sciences, Inc. (United States)
  • Biogen (United States)
  • Amgen Inc. (United States)
  • Merck & Co. (United States)
  • Sanofi (France)
  • Roche Holding AG (Switzerland)
  • Lonza Group AG (Switzerland)
Additional players considered in the study are as follows:
Regeneron Pharmaceuticals (United States) , Alexion Pharmaceuticals (United States) , Vertex Pharmaceuticals (United States) , Incyte Corp. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation